Toxicon : official journal of the International Society on ToxinologyHumansBotulinum ToxinsType ARetrospective StudiesMale
Two-year real-world retrospective safety evaluation with onabotulinumtoxinA across multiple therapeutic indications: Findings from the SYNCHRONIZE study.
Grace Forde, Kimberly Becker Ifantides, Angeli Mayadev, Atul T Patel, Christopher Rhyne, Theodore Brown, Ritu Singh, Mariana Nelson, Ahunna Ukah, Simona Battucci, Benjamin M Brucker
Published: 202610.1016/j.toxicon.2025.108666
Abstract
OnabotulinumtoxinA (onabotA) is approved for the treatment of various therapeutic indications, which require retreatment. In clinical practice, many patients receive onabotA for multiple therapeutic indications concomitantly over extended time period…
Preview only. Read the full abstract at the source